Prostate cancer genetic risk screening study for men
Part of Cancer, Digestive system, Genetic & congenital, Hormones & metabolism, Kidney & urinary clinical trials.
This study looks at your personal and family risk for prostate cancer and helps decide who should have extra screening like MRI. It may help you find cancer earlier if you are at higher genetic risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man age 35 to 74
- You have not been diagnosed with prostate cancer before
- You can live independently for at least 10 more years (based on your health)
- You fit one of these risk groups: (A) a known prostate-cancer–related gene change, (B) strong family history with a negative gene test, or (C) you are Black American or Black Caribbean with African ancestry on both sides
- You can safely have a prostate MRI
- You can receive MRI contrast dye (the contrast liquid used for the scan)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how inherited risk (family history or gene findings) relates to screening and treatment for prostate cancer. If you qualify, you may be offered prostate screening tests and follow-up to see how well risk information predicts next steps.
This study uses a genetic risk score and a special MRI scan to find prostate cancers that are more likely to be dangerous. It aims to see if combining these tests can better identify which men need a biopsy.
This study tries to personalize prostate cancer care by matching treatment decisions to a person’s specific risk profile. You might be able to join if you have certain types of prostate cancer or a strong family history and meet health-function requirements.
This trial studies how well “active surveillance” works for men with prostate cancer who are considered higher risk because of family history or genetics. It aims to safely monitor the cancer and decide the best timing for treatment if needed, while tracking side effects and follow-up success.
This study runs a clinic for men who are at higher-than-average risk of prostate cancer because of family history or a genetic change. It may help with early prevention planning and follow-up for people who could be at greater risk.
This trial looks for specific DNA repair changes in men with prostate cancer. It tests if these genetic features can help guide treatment decisions. You may join if you have high-risk localized, newly metastatic, or advanced prostate cancer and have tissue available for testing.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.